RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and ...

RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and ...

Peptides are the new ‘wonder’ ingredient in beauty products and health supplements. On TikTok, videos tagged #peptidetherapy have been viewed more than 20million times. And A-listers including ...

Toni Lorene, a three-chair turn on the current season of "The Voice," is a Houston native who attended Alief Taylor High School and spent summers at Ensemble Theatre camps. But right now, she ...

Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...

The first re-invented with brio and barely echoing the original, and the second – one of the highpoints of the album – in essence true to the New Orleans ballad, but sounding more chilled and jazzier, ...

Evommune, a biotechnology company developing treatments for chronic inflammatory conditions, revealed plans to go public in a Thursday filing with the Securities and Exchange Commission. Evommune ...

NEW YORK – Kernal Biologics on Tuesday said the Advanced Research Projects Agency for Health (ARPA-H) awarded the company up to $48 million to support development of its in vivo mRNA-encoded CAR ...

Kernal Biologics, Inc., a venture-backed TechBio company pioneering novel therapeutics to program human cells directly inside the body, today announced that it has been awarded up to $48 million in ...

On his first studio album in seven years, Plano-raised singer Boz Scaggs dips into the Great American Songbook and also revisits a tune he wrote before “Lido Shuffle” and “Lowdown” made him a star in ...

-Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy- -As of the August 31, 2025 data cut-off date, all seven ...